IRLAB Therapeutics AB announced appointment of members of nomination committee. Nomination committee consist of Daniel Johnsson, entrepreneur, business developer and investor, appointed by a group of shareholders representing about 23% of shares and votes, Bo Rydlinger, chairman of the nomination committee, background from banking and investments, appointed by a group of shareholders representing about 19% of shares and votes, Clas Sonesson, Chief Scientific Officer at the company and one of company founders Appointed by a group of shareholders that consists of the company founders representing about 11% of shares and votes and Gunnar Olsson, chairman of the board of the company.